Does Blood Flow Restriction Training Improve Quadriceps Function After Arthroscopic Knee Surgery?
1 other identifier
interventional
150
1 country
1
Brief Summary
The purpose of this study is to evaluate the effectiveness of physical therapy (PT) plus BFR training compared to PT alone (without BFR training) after ACL reconstruction in patients who require extended limited weight bearing through assessment of patient reported outcomes and functional testing. The hypothesis is that PT plus BFR training will mitigate the loss of quadriceps muscle cross-sectional area, strength, and function while also improving early clinical and functional results.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2017
CompletedFirst Posted
Study publicly available on registry
March 30, 2017
CompletedStudy Start
First participant enrolled
November 21, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedMay 4, 2022
May 1, 2022
5 years
March 23, 2017
May 3, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Quadriceps Muscle Cross-Sectional Area (CSA) as Assessed by Ultrasound
Initiation of PT is 1 month after surgery
at start of PT, 1 month after start of PT
Change in Quadriceps Muscle Cross-Sectional Area (CSA) as Assessed by Ultrasound
Initiation of PT is 1 month after surgery
at start of PT, 2 months after start of PT
Change in Quadriceps Muscle Cross-Sectional Area (CSA) as Assessed by Ultrasound
Initiation of PT is 1 month after surgery
at start of PT, 5 months after start of PT
Secondary Outcomes (41)
Change in Passive Range of Motion as Assessed by Goniometer
at start of PT, 1 month after start of PT
Change in Passive Range of Motion as Assessed by Goniometer
at start of PT, 2 months after start of PT
Change in Passive Range of Motion as Assessed by Goniometer
at start of PT, 5 months after start of PT
Change in Active Range of Motion as Assessed by the Straight-Leg-Raise Test
at start of PT, 1 month after start of PT
Change in Active Range of Motion as Assessed by the Straight-Leg-Raise Test
at start of PT, 2 months after start of PT
- +36 more secondary outcomes
Study Arms (2)
Physical therapy (PT) plus blood flow restriction (BFR)
EXPERIMENTALPhysical therapy consists of two or three 90-minute sessions per week for 6 weeks and a minimum of 18 visits required for study inclusion. With BFR, exercises will be performed at 30% one-rep max with the BFR cuff placed around the proximal thigh and inflated to 80% of limb occlusion pressure (avg: 150 mmHg).
Physical therapy
ACTIVE COMPARATORPhysical therapy consists of two or three 90-minute sessions per week for 6 weeks and a minimum of 18 visits required for study inclusion.
Interventions
With BFR, exercises will be performed at 30% one-rep max with the BFR cuff placed around the proximal thigh and inflated to 80% of limb occlusion pressure (avg: 150 mmHg).
Physical therapy consists of two or three 90-minute sessions per week for 6 weeks and a minimum of 18 visits required for study inclusion.
Eligibility Criteria
You may qualify if:
- Anterior cruciate ligament (ACL) reconstruction with concomitant meniscus or cartilage restoration procedures
- Adherence to modified weight bearing status before initiation of PT
- Expected participation in recreational or competitive sports after release to full activities
You may not qualify if:
- Unable to attend (or participate in) physical therapy
- Pregnancy
- Malignancy
- Fracture
- Peripheral vascular disease
- History of deep vein thrombosis (DVT)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Walter R Lowe, MD
The University of Texas Health Science Center, Houston
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Blinding is not possible given the nature of the intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Chair
Study Record Dates
First Submitted
March 23, 2017
First Posted
March 30, 2017
Study Start
November 21, 2017
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
May 4, 2022
Record last verified: 2022-05